<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/07883787-C252-44BB-81D1-81AECF29A9A1"><gtr:id>07883787-C252-44BB-81D1-81AECF29A9A1</gtr:id><gtr:name>Diamond Light Source</gtr:name><gtr:address><gtr:line1>Diamond House</gtr:line1><gtr:line2>Harwell Science and Innovation Camp</gtr:line2><gtr:line3>Didcot</gtr:line3><gtr:line4>Oxfordshire</gtr:line4><gtr:postCode>OX11 0DE</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/F1E10ED4-50B8-4490-A625-C36A9C7B0F25"><gtr:id>F1E10ED4-50B8-4490-A625-C36A9C7B0F25</gtr:id><gtr:name>Nagasaki International University</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>Life Sciences</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/07883787-C252-44BB-81D1-81AECF29A9A1"><gtr:id>07883787-C252-44BB-81D1-81AECF29A9A1</gtr:id><gtr:name>Diamond Light Source</gtr:name><gtr:address><gtr:line1>Diamond House</gtr:line1><gtr:line2>Harwell Science and Innovation Camp</gtr:line2><gtr:line3>Didcot</gtr:line3><gtr:line4>Oxfordshire</gtr:line4><gtr:postCode>OX11 0DE</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/F1E10ED4-50B8-4490-A625-C36A9C7B0F25"><gtr:id>F1E10ED4-50B8-4490-A625-C36A9C7B0F25</gtr:id><gtr:name>Nagasaki International University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/0469D140-6391-49B7-844D-57C5ECD66BE6"><gtr:id>0469D140-6391-49B7-844D-57C5ECD66BE6</gtr:id><gtr:firstName>Bernadette</gtr:firstName><gtr:surname>Byrne</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/4E71F9D5-F829-47CD-A36E-6DACB7F022F1"><gtr:id>4E71F9D5-F829-47CD-A36E-6DACB7F022F1</gtr:id><gtr:firstName>So</gtr:firstName><gtr:surname>Iwata</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/0DD86036-0C18-40AD-8B5B-2AC8036F6338"><gtr:id>0DD86036-0C18-40AD-8B5B-2AC8036F6338</gtr:id><gtr:firstName>Elisabeth</gtr:firstName><gtr:otherNames>Paula</gtr:otherNames><gtr:surname>Carpenter</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=BB%2FD019516%2F1"><gtr:id>CD033C8A-B39B-49B6-9D99-F154F42B9820</gtr:id><gtr:title>Stuctural studies on human erythrocyte BAND-3</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/D019516/1</gtr:grantReference><gtr:abstractText>The Human Erythrocyte Anion exchanger, AE1, also known as Band 3, allows bicarbonate to cross the red blood cell membrane in exchange for chloride. This is an essential process in allowing the bloodstream to transport large quantities of carbonate to the lungs. Band 3 is also associated with a number of human disease states. In order to understand the precise mechanism of action of the protein and reveal further details on these disease states it is necessary to obtain precise structural information for the human form of Band 3 membrane domain. The most suitable technique for this is X-ray crystallography. The structure determination of human membrane proteins is extremely challenging as evidenced by the fact that no X-ray structure has been solved. So far it has been possible to obtain highly pure Band 3 protein from human red blood cells which has yielded crystals. However the data obtained from the X-ray analysis of the crystals is not of sufficient quality to solve the structure. This application focuses on the optimisation of the Band 3 crystals in order to obtain high quality data suitable for structure determination.</gtr:abstractText><gtr:technicalSummary>The Human Erythrocyte Anion exchanger, AE1, also known as Band 3, acts as an anion transporter in red blood cells, allowing bicarbonate to cross the membrane in exchange for chloride. The protein can be cleaved into the two domains which maintain functional integrity. The C-terminal membrane domain is predicted to have fourteen transmembrane helices and is responsible for the anion transport activity. A very low resolution (20 A) 3D map of the dimeric membrane domain was obtained using electron microscopy more than a decade ago. However in order to reveal molecular detail on the structure-function relationships of the membrane domain of Band 3 it is necessary to obtain high resolution structural information for the protein using the technique of X-ray crystallography. The C-terminal domain of Band 3 has been isolated from human red blood cells and crystals obtained which diffract to 7 A. This application is focussed on improving the crystals in order to obtain high resolution diffraction data suitable for solving the structure. Sample quality will be improved in order to allow reproducibility of crystals. In addition, we will submit the Band 3 protein to our tried and tested optimisation strategy; screening in particular additives and detergents in order to obtain better diffracting crystals. We will also identify alternative crystal forms which may produce better diffracting crystals. These rational screening approaches have resulted in a number of membrane protein structures from our lab. However in some cases it may be necessary to use alternative methods such as extending the hydrophilic domain of the membrane protein in order to obtain well-diffracting crystals. We will use both monocolonal antibodies and artificial binding proteins to extend the hydrophilic domain of band 3. We will also establish expression system of Band 3 using Pichia pastoris for functional and structural studies.</gtr:technicalSummary><gtr:fund><gtr:end>2010-02-28</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2006-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>419739</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Nagasaki International University</gtr:collaboratingOrganisation><gtr:country>Japan</gtr:country><gtr:description>Band3</gtr:description><gtr:id>88C256A6-D6AD-42AC-A58C-3F95391B64FA</gtr:id><gtr:impact>We have solved the structure and will soon deposit the coordinates with PDB. We have published some results.</gtr:impact><gtr:partnerContribution>He provided the protein sample.</gtr:partnerContribution><gtr:piContribution>Prof. Hamasaki has been our biochemical collaborator.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>DIAMOND Light Source Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Diamond Membrane Protein Laboratory</gtr:description><gtr:id>7EB1BEA0-9FF7-40D7-ABA2-4F25A587CC35</gtr:id><gtr:impact>We have co-organised the Diamond Membrane Protein Laboratory and our users and ourselves made publications.</gtr:impact><gtr:partnerContribution>Providing the space and the technical assistance</gtr:partnerContribution><gtr:piContribution>Co-organise Diamond Membrane protein Laboratory</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Diamond Membrane Protein Laboratory</gtr:description><gtr:end>2016-02-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:fundingRef> WT099165/Z/12/Z</gtr:fundingRef><gtr:id>223548ED-AFDC-42AC-BF8D-8D552002AA02</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>162012160</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC Diamond Professorial fellow</gtr:description><gtr:end>2014-12-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/G023425/1</gtr:fundingRef><gtr:id>BF394C3D-196C-4986-A873-6C1BDC0723F4</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>To obtain well diffracting Band3 crystals, we have raised antibodies which form stable complexes with band 3. Currently we are filling a patent application for this antibody, which can be used for biochemical studies of Band3. To obtain the antibodies, we have developed new method to screen antibody suitable for membrane protein crystallisation. This method has been used in the research community.</gtr:description><gtr:firstYearOfImpact>2011</gtr:firstYearOfImpact><gtr:id>6C2B0015-AF55-45A2-A380-20B8D5022F53</gtr:id><gtr:impactTypes><gtr:impactType>Cultural</gtr:impactType></gtr:impactTypes><gtr:sector>Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>The Human Erythrocyte Anion exchanger, AE1, also known as Band 3, allows bicarbonate to cross the red blood cell membrane in exchange for chloride. This is an essential process in allowing the bloodstream to transport large quantities of carbonate to the lungs. Band 3 is also associated with a number of human disease states. In order to understand the precise mechanism of action of the protein and reveal further details on these disease states it is necessary to obtain precise structural information for the human form of Band 3 membrane domain. The most suitable technique for this is X-ray crystallography. The structure determination of human membrane proteins is extremely challenging as evidenced by the fact that no X-ray structure has been solved. So far it has been possible to obtain highly pure Band 3 protein from human red blood cells which has yielded crystals. However the data obtained from the X-ray analysis of the crystals is not of sufficient quality to solve the structure. This application focuses on the optimisation of the Band 3 crystals in order to obtain high quality data suitable for structure determination.</gtr:description><gtr:exploitationPathways>Structure of Band3 and X-ray diffraction data from the crystals of Band 3 will be deposited with PDB. This will be used in future drug discovery</gtr:exploitationPathways><gtr:id>A26A9A6E-C5DC-4B8A-B564-845F4C9EA1A1</gtr:id><gtr:sectors><gtr:sector>Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors><gtr:url>http://www.imperial.ac.uk/people/s.iwata</gtr:url></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D3B92EFD-0E13-4D50-AB45-DB4EF3009D2D"><gtr:id>D3B92EFD-0E13-4D50-AB45-DB4EF3009D2D</gtr:id><gtr:title>Cloning, expression and purification of the anion exchanger 1 homologue from the basidiomycete Phanerochaete chrysosporium.</gtr:title><gtr:parentPublicationTitle>Protein expression and purification</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/71b76ce9408b2744c423f8c30bc6611d"><gtr:id>71b76ce9408b2744c423f8c30bc6611d</gtr:id><gtr:otherNames>Tokuda N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1046-5928</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/969D7E5A-07A3-4C6F-8FDB-2FF329A640FC"><gtr:id>969D7E5A-07A3-4C6F-8FDB-2FF329A640FC</gtr:id><gtr:title>Crystal structure of the anion exchanger domain of human erythrocyte band 3.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/430cdf11ef639ce8ace97a2c581ca5e2"><gtr:id>430cdf11ef639ce8ace97a2c581ca5e2</gtr:id><gtr:otherNames>Arakawa T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/D019516/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>